Neal Kumar Agarwal, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7051 Fm 1464 Rd Rm 317, Richmond, TX 77407 Phone: 128-176-6381 |
Mark Cesta, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1705 Jackson St, Richmond, TX 77469 Phone: 616-734-0335 |
Dr. Benjamin E Oei, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1705 Jackson St, Richmond, TX 77469 Phone: 281-341-4818 |
Mary Davidson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1705 Jackson St, Richmond, TX 77469 Phone: 616-734-0335 Fax: 616-949-8540 |
Dr. Rajan U Popat, M.D. Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 17707 Galloway Forest Dr, Richmond, TX 77407 Phone: 248-763-3681 |
Reilly Talbot, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 7051 Fm 1464 Rd Ste A, Richmond, TX 77407 Phone: 281-766-3811 |
Karen Richardson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1705 Jackson St, Richmond, TX 77469 Phone: 616-734-0335 |
Cynthia Ngozichukwuka Obi, M.D. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 24948 Fm 1093 Rd, Suite 205, Richmond, TX 77406 Phone: 281-347-2228 |
News Archive
If you were born during 1945-1965, talk to your doctor about getting tested for hepatitis C. Baby boomers are five times more likely than other adults to be infected. In fact, 75 percent of adults with hepatitis C were born during these years.
NASA's Johnson Space Center has awarded a five-year, $120 million extension of its cooperative agreement with the National Space Biomedical Research Institute, or NSBRI, of Houston.
FDA today approved the use of oral fluid samples with a rapid HIV diagnostic test kit that provides screening results with over 99 percent accuracy in as little as 20 minutes. Until now, all rapid HIV tests required the use of blood in order to get such rapid results.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the resubmission of the New Drug Application (NDA) for sugammadex sodium injection has been accepted for review by the U.S. Food and Drug Administration (FDA). Merck expects the FDA's review to be completed in the first half of 2013.
› Verified 2 days ago